Immunome Inc. - Common Stock (IMNM)

CUSIP: 45257U108

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
-2,256,720
Put/Call ratio
510%
SEC-reported price per share
$21.87
Indexed holders
200
Value change
-$44,791,172
Number of buys
115
Open additional details 1 more signal available
Number of sells
73
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
113,987,415

Security key

45257U108

Report period

Q1 2026

Indexed institutions

200

Top holders

10

Ownership snapshot

Top reported holders of IMNM - Immunome Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
6/15
Latest evidence
31 Dec 2025
13F 13D/G Lead comparable stake: 15% 9 rows are not safely comparable across share classes. 13D/G row: FMR LLC Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 15%.

6 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Comparable ownership Top 5
FMR LLC 15%
Immunome Aggregator, LP 6%
Redmile Group, LLC 4.9%
EcoR1 Capital, LLC 4.7%
Enavate Sciences GP, LLC 4.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F 13D/G
Company
15%
Reported 13D/G · 30 Sep 2025
$355,487,900
16,549,716 shares
— 31 Dec 2025
Immunome Aggregator, LP
13D/G
6%
Reported 13D/G · 31 Jan 2025
$40,628,327
4,768,583 shares
$0 31 Jan 2025
Redmile Group, LLC
13F 13D/G
Company
4.9%
Reported 13D/G · 31 Mar 2026
$122,830,910
5,718,385 shares
— 31 Dec 2025
EcoR1 Capital, LLC
13F 13D/G
Company
4.7%
Reported 13D/G · 31 Mar 2025
$61,338,073
2,855,590 shares
— 31 Dec 2025
Enavate Sciences GP, LLC
13F 13D/G
Company
4.3%
Reported 13D/G · 18 Dec 2025
$102,429,163
4,768,583 shares
— 31 Dec 2025
Janus Henderson Group Ltd.
13F 13D/G
Company · JANUS HENDERSON GROUP PLC
2.2%
Reported 13D/G · 31 Mar 2025
$17,873,800
832,078 shares
— 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
200
Shares
116,673,843
Indexed holders
200
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 indexed holders
184
Q1 2026 indexed holders
200
Indexed holder difference
16
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .